Led by University of Modena and Reggio Emilia, Spoke 1 coordinates activities related to RNA-based technologies in Genetic Diseases.

Led by Sapienza University of Rome, Spoke 2 coordinates activities related to RNA-based technologies in Cancer.

Led by the Italian Institute of Technology, Spoke 3 coordinates activities related to RNA-based technologies in Neurodegeneration.

Led by University of Padua, Spoke 4 coordinates activities related to RNA-based technologies in Metabolic and Cardiovascular Diseases.

Led by University of Siena, Spoke 5 coordinates activities related to RNA-based technologies in Infectious and Inflammatory Diseases.

Led by National Research Council of Italy, Spoke 6 coordinates activities related to RNA-based technologies for RNA Drug Development.

Led by University of Bari Aldo Moro, Spoke 7 coordinates Biocomputing activities related to RNA-based technologies.

Led by University of Naples Federico II, Spoke 8 coordinates activities related to Platforms for RNA/DNA Delivery.

Led by University of Milan, Spoke 9 coordinates the Competence Center on RNA Drug Pharmacology. From target to therapy: pharmacology, safety, and regulatory competence center.

Led by IRCCS Bambino Gesù Children’s Hospital in Rome (OPBG), Spoke 10 coordinates activities related to pre-clinical development, Good Manufacturing Practices (GMP) and clinical trials of Gene Therapy Medicinal Products (GTMPs).